Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4QTD
|
||||
| Drug Name |
(R)-5-(4-Acetyl-piperazin-1-yl)-2-[benzo[1,3]dioxol-5-ylmethyl-(4-methoxy-benzenesulfonyl)-amino]-5-oxo-pentanoic acid hydroxyamide
|
||||
| Synonyms |
CHEMBL432532
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H32N4O9S
|
||||
| Canonical SMILES |
COc1ccc(cc1)S(=O)(=O)N(Cc2ccc3OCOc3c2)[C@H](CCC(=O)N4CCN(CC4)C(=O)C)C(=O)NO
|
||||
| InChI |
InChI=1S/C26H32N4O9S/c1-18(31)28-11-13-29(14-12-28)25(32)10-8-22(26(33)27-34)30(16-19-3-9-23-24(15-19)39-17-38-23)40(35,36)21-6-4-20(37-2)5-7-21/h3-7,9,15,22,34H,8,10-14,16-17H2,1-2H3,(H,27,33)/t22-/m1/s1
|
||||
| InChIKey |
DVXDZENYHAGFRW-JOCHJYFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Interstitial collagenase | Target Info | [1587926] | ||
| Neutrophil collagenase | Target Info | [1587926] | |||
| WikiPathways | TGF beta Signaling Pathway | ||||
| Bladder Cancer | |||||
| Activation of Matrix Metalloproteinases | |||||
| Degradation of collagen | |||||
| Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
| Oncostatin M Signaling Pathway | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Cell surface interactions at the vascular wall | |||||
| Matrix MetalloproteinasesWP2769:Activation of Matrix Metalloproteinases | |||||
| Matrix Metalloproteinases | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.